Ekso Bionics is committed to applying the latest technology and engineering to help people rethink current physical limitations and achieve the remarkable. Originally Berkeley Bionics, Ekso Bionics was founded in Berkeley, California in 2005. Since inception Ekso Bionics has forged partnerships with world-class institutions like UC Berkeley, received research grants from the Department of Defense and licensed technology to the Lockheed Martin Corporation. Today Ekso Bionics continues to pioneer the field of exoskeletons, designing and creating some of the most forward-thinking and innovative solutions for people looking to augment human mobility and capability.
TypePublic
HQRichmond, US
Founded2005
Size (employees)116 (est)
Websiteeksobionics.com
Ekso Bionics was founded in 2005 and is headquartered in Richmond, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Ekso Bionics

Jack Peurach

Jack Peurach

President and Chief Executive Officer
Max Scheder-Bieschin

Max Scheder-Bieschin

CFO
Russ Angold

Russ Angold

CTO
Show more

Ekso Bionics Office Locations

Ekso Bionics has an office in Richmond
Show all (1)
Report incorrect company information

Ekso Bionics Financials and Metrics

Ekso Bionics Revenue

Embed Graph
Ekso Bionics's revenue was reported to be $7.35 m in FY, 2017
USD

Revenue (Q2, 2018)

5.5 m

Gross profit (Q2, 2018)

1.7 m

Gross profit margin (Q2, 2018), %

31.6%

Net income (Q2, 2018)

(15.9 m)

EBIT (Q2, 2018)

(15.8 m)

Market capitalization (19-Sep-2018)

128.4 m

Closing stock price (19-Sep-2018)

2.1

Cash (30-Jun-2018)

13.9 m
Ekso Bionics's current market capitalization is $128.4 m.
Annual
USDFY, 2016FY, 2017

Revenue

14.2 m7.4 m

Cost of goods sold

11.3 m5.3 m

Gross profit

2.9 m2.1 m

Gross profit Margin, %

21%28%
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018Q2, 2018

Revenue

1.2 m1.6 m1.7 m2.1 m2.9 m8.5 m1.6 m1.6 m1.4 m2.5 m5.5 m

Cost of goods sold

1.2 m1.1 m1.3 m1.6 m2.4 m7 m1.3 m1.2 m1.1 m1.8 m3.8 m

Gross profit

45.6 k479.8 k403 k502 k468 k1.5 m203 k403 k352 k767 k1.7 m

Gross profit Margin, %

4%30%24%24%16%18%13%25%25%30%32%
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017

Cash

25.2 m19.6 m16.8 m27.8 m

Accounts Receivable

Inventories

388 k436 k1.6 m3 m

Current Assets

29.3 m25.2 m20.7 m34.9 m
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018Q2, 2018

Cash

11 m7.2 m21.1 m16.3 m11.2 m12.3 m4.7 m12.8 m9.4 m20.6 m13.9 m

Accounts Receivable

1.5 m1.9 m1.5 m2.4 m2.2 m2.4 m1.6 m2.2 m1.3 m

Inventories

1.3 m864.4 k838 k1.2 m1.2 m2.5 m2.4 m1.9 m1.8 m2.8 m2.4 m

Current Assets

15.3 m11.7 m25.6 m22.2 m17.2 m18.2 m9.4 m17.6 m13.3 m27.9 m20.4 m
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(33.8 m)(19.6 m)(23.5 m)(29.1 m)

Depreciation and Amortization

745 k933 k1.9 m1.7 m

Inventories

354 k(200 k)(541 k)(2.1 m)

Accounts Payable

(716 k)1.7 m(818 k)77 k
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018Q2, 2018

Net Income

56.1 m12 m(4.1 m)(5.6 m)(5.2 m)(3.7 m)(5.8 m)(8.5 m)(8.3 m)(7.9 m)(15.9 m)

Depreciation and Amortization

428 k888 k

Inventories

(286 k)(198 k)

Accounts Payable

1.2 m1.1 m1.5 m2.3 m2.1 m3.6 m2.1 m1.4 m2.9 m1 m210 k
USDY, 2018

Financial Leverage

3 x
Show all financial metrics
Report incorrect company information

Ekso Bionics Online and Social Media Presence

Embed Graph
Report incorrect company information

Ekso Bionics Company Life and Culture

Report incorrect company information